These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9638016)

  • 21. Work-up of the abnormal mammogram for palpable and nonpalpable breast masses.
    Schepps B; Spencer PK; Scola FH; Thompson W
    R I Med; 1992 Jan; 75(1):16-20. PubMed ID: 1543887
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical results of specialized prophylactic mammography screenings of industrial workers].
    Orlov OA
    Vopr Onkol; 2002; 48(1):95-8. PubMed ID: 12101578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer. The breast report.
    Sadler C
    Nurs Times; 1987 Oct 7-13; 83(40):31-2. PubMed ID: 3317281
    [No Abstract]   [Full Text] [Related]  

  • 24. [The value of the localization technique of occult breast changes with reference to future screening programs].
    Hess T; Benz J; Juchler A
    Helv Chir Acta; 1992 May; 59(1):263-8. PubMed ID: 1526839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diseases of the female breast: screening, mammography, ultrasound].
    Otto RC
    Ther Umsch; 1993 May; 50(5):323-33. PubMed ID: 8378888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dedicated screening mammography for diagnosis of small breast cancer.
    Kirshtein B; Crystal P; Koretz M; Strano S
    World J Surg; 2004 Mar; 28(3):232-5. PubMed ID: 14961201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing to core biopsy in an NHS breast screening unit.
    Britton PD; Flower CD; Freeman AH; Sinnatamby R; Warren R; Goddard MJ; Wight DG; Bobrow L
    Clin Radiol; 1997 Oct; 52(10):764-7. PubMed ID: 9366536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of mammographic localization of occult breast cancer at a teaching community hospital.
    Greene FL; Martin P; Rotz T
    J S C Med Assoc; 1990 Mar; 86(3):155-7. PubMed ID: 2325372
    [No Abstract]   [Full Text] [Related]  

  • 29. Screening for breast cancer.
    George WD; Gleave EN; England PC; Wilson MC; Sellwood RA; Asbury D; Hartley G; Barker PG; Hobbs P; Wakefield J
    Br Med J; 1976 Oct; 2(6040):858-60. PubMed ID: 990724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of abnormal mammography results and palpable breast abnormalities.
    Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
    Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammography screening for breast cancer.
    Kopans DB
    Cancer; 1993 Sep; 72(6):1809-12. PubMed ID: 8364858
    [No Abstract]   [Full Text] [Related]  

  • 32. Short-term cessation of hormone replacement therapy and improvement of mammographic specificity.
    Harvey JA; Pinkerton JV; Herman CR
    J Natl Cancer Inst; 1997 Nov; 89(21):1623-5. PubMed ID: 9362162
    [No Abstract]   [Full Text] [Related]  

  • 33. The abnormal mammogram in clinically normal breasts: a challenge for surgeons.
    Deschênes L
    Can J Surg; 1995 Apr; 38(2):110-1. PubMed ID: 7728662
    [No Abstract]   [Full Text] [Related]  

  • 34. The Japanese Breast Cancer Society clinical practice guidelines for screening and imaging diagnosis of breast cancer, 2015 edition.
    Tozaki M; Kuroki Y; Kikuchi M; Kojima Y; Kubota K; Nakahara H; Ito Y; Mukai H
    Breast Cancer; 2016 May; 23(3):357-66. PubMed ID: 27052720
    [No Abstract]   [Full Text] [Related]  

  • 35. Stereotactic large-gauge core biopsy: its role in the diagnosis of non-palpable mammographic abnormalities presenting to a screening service.
    Sutton S; Dahlstrom JE; Jain S
    Australas Radiol; 1997 May; 41(2):103-8. PubMed ID: 9153803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Is screening for breast cancer with mammography really justifiable?].
    Engel J; Hölzel D
    Strahlenther Onkol; 2000 Jul; 176(7):336-7. PubMed ID: 11001742
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experiences of the Bavarian mammography screening program].
    Nährig J; Höfler H; Heywang-Köbrunner SH; Prat N; Hölzel D; Wünsch PH; Lebeau A
    Pathologe; 2006 Sep; 27(5):387-91. PubMed ID: 16858556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for breast cancer with mammography.
    Dixon-Woods M; Baum M; Kurinczuk JJ
    Lancet; 2001 Dec 22-29; 358(9299):2166-7; discussion 2167-8. PubMed ID: 11784657
    [No Abstract]   [Full Text] [Related]  

  • 39. What is the difference between diagnostic mammography and screening mammography?
    Hoygaard E
    NAACOG Newsl; 1992 Apr; 19(4):8. PubMed ID: 1625689
    [No Abstract]   [Full Text] [Related]  

  • 40. Screening mammography: value in women 35-39 years old.
    Liberman L; Dershaw DD; Deutch BM; Thaler HT; Lippin BS
    AJR Am J Roentgenol; 1993 Jul; 161(1):53-6. PubMed ID: 8517320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.